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Abstract                                                                                                              
                            
Recently, global concern has been raised to investigate the ecological system, were 
pharmaceutical pollutants affect negatively on aquatic life and underground water, 
researchers investigated main causes of its environmental impacts. Many Pharmaceutical 
compounds  has been detected in wastewater samples in many areas. In Palestine, were 
wadi Al-Qilt catchment area has been affected by many pharmaceuticals. Upon that, this 
study investigated the occurrence of main pharmaceuticals in Al Qilt catchment area that 
affected underground water, in addition of reviewing information on sorption and 
transformation of three main pharmaceuticals, in addition to assessing the risks of these 
pharmaceuticals on public health. HPLC MS/MS analysis has been used to investigate the 
presence of these pharmaceuticals.  
The Al-Qilt catchment is located in the West Bank on the western side of the Jordan Valley 
covering about 173 km2; it is characterized by a steep relief with elevations in the range of 
700 m.a.s.l in the western part to the range of -250 m.b.s.l in the eastern part. At Al-Qilt, 
there are about 96,935 inhabitants from Palestinian communities and Israeli colonies, they 
discharge about 14,000 m3/d of wastewater and only about 30% of these quantities is 
treated, then it is mixed again with raw wastewater. Moreover, at Al-Qilt the rainfall is 
estimated by 600 mm/a in the west and it is 150 mm/a in the east area, which resulted of an 
average rainfall over the catchment is 400 mm/a. The long term observations of flow 
mainly for Al-Qilt springs range from 3.0 to 12.0 Mcm/a, and the continuous base flow for 
the Ras Al-Qilt spring of around 300 l/s (PWA, 2009). 
In this study, sixteen pharmaceuticals were analyzed using HPLC method, namely: 
Phenacetin, Indomethacin, Diclofinac, Ibuprofen, Fenoprofen, Ketoprofen, Gemfibrozil, 
Fenofibrat, Fenofibrinsaure, Bezafibrat, Clofibrinsäure, Carbamazepin, Pentoxifyllin, 
Naproxen, Diazepam, Etofibrat. From all of those pharmaceuticals, only Ibuprofen, 
Diclofinac and Carbamazepne were detected in a considered concentrations, while the 
others were nil. These compounds are examples of pharmaceuticals that are released into 
the environment, all are marketed in the Palestinian market (pharmacies), private clinics, 
hospitals either for human veterinary use. Ibuprofen was detected only in the AWWTP 
inffluent in the first and second sampling time with a concentration of 300 ng/L and 1000 
ng/L respectively and then disappeared in the other sampling stations because it was 
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eliminated after AWWTP. Diclofinac was detected in AWWTP influent in the two 
sampling time with a concentration of 310 ng/L in the first sampling time and 1450ng/L in 
the second sampling time. This concentration was decreased after treatment to 50ng/L and 
225ng/L respectively. Then it was disappeared in Ras Al-Qilt and in Al Murashahat. On 
the other hand, Carbamazepine was detected in AWWTP influent with a concentration of 
1995 ng/L in the first sampling time and then decreased respectively to become 1750 ng/L 
in AWWTP effluent, 1550 ng/L in wadi Mukhmas, 64 ng/L in Ras Al Quilt to reach a 
value lower than background in al Murashahat influent and effluent . The results revealed 
that the concentration of diclofinac and ibuprofen were below the background then there 
have no risk on al qilt catchment area, but the concentration of the carbamazepine in the 
second sampling time in Al Murashat influent and effluent was 48ng\L and 44ng\L 
respectively and this concentration was very low and near the background, then we can 
conclude that there are no risk of carbamazepine on drinking water in Al Murashahat 
station. 
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    ﺹﺍﻝﻤﻠﺨ
 ﺍﻝﺼﻴﺩﻻﻨﻴﺔ ﻝﻤﻠﻭﺜﺎﺕﻭﺠﺩ ﺒﺄﻥ ﺍ ﻓﻘﺩﺘﺯﺍﻥ ﺍﻝﺒﻴﺌﻲ، ﻻﺍﺯﺩﺍﺩ ﺍﻻﻫﺘﻤﺎﻡ ﺍﻝﻌﺎﻝﻤﻲ ﺒﻀﻤﺎﻥ ﺍﻓﻲ ﺍﻵﻭﻨﺔ ﺍﻷﺨﻴﺭﺓ، 
ﺩﺭﺍﺴﺔ ﻥ ﻴﺍﻝﺒﺎﺤﺜﻤﻤﺎ ﺍﺴﺘﺩﻋﻰ ﺍﻝﻌﺩﻴﺩ ﻤﻥ  ﻝﺤﻴﺎﺓ ﺍﻝﻤﺎﺌﻴﺔ ﻭﺍﻝﻤﻴﺎﻩ ﺍﻝﺠﻭﻓﻴﺔ،ﺍﺘﺅﺜﺭ ﺒﺸﻜل ﺴﻠﺒﻲ ﻋﻠﻰ 
ﻤﻴﺎﻩ ﺍﻝﺼﺭﻑ ﻀﻤﻥ ﻋﻴﻨﺎﺕ  ﺍﻝﺼﻴﺩﻻﻨﻴﺔ ﻝﻤﻠﻭﺜﺎﺕﻤﻥ ﺘﻠﻙ ﺍﻭﻗﺩ ﺘﻡ ﺍﻝﻜﺸﻑ ﻋﻥ ﺍﻝﻌﺩﻴﺩ . ﺍﻝﺒﻴﺌﻴﺔ ﻬﺎﺘﺄﺜﻴﺭﺍﺘ
ﻭﺍﻝﺫﻱ ﺘﻠﻘﻰ ﻓﻴﻪ ﻤﺨﻠﻔﺎﺕ ﺍﻝﻘﻠﻁ ﺤﻴﺙ ﻴﻘﻊ ﻤﺴﺘﺠﻤﻊ ﻭﺍﺩﻱ ﻓﻲ ﻓﻠﺴﻁﻴﻥ، ﻭ. ﻤﻨﺎﻁﻕ ﻋﺩﺓﺍﻝﺼﺤﻲ ﻓﻲ 
ﺍﻝﺘﻌﺭﻑ ﻋﻠﻰ ﻨﺴﺏ ﻭﺠﻭﺩ ﻭﺘﺄﺜﻴﺭ ﻫﺫﻩ ﺍﻝﺩﺭﺍﺴﺔ ﻫﺩﻓﺕ ﺒﻨﺎﺀ ﻋﻠﻰ ﺫﻝﻙ، . ﻴﺔﺍﻝﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻝﺼﻴﺩﻻﻨ
ﻓﻀﻼﹰ ﻋﻥ ﺍﺴﺘﻌﺭﺍﻀﻬﺎ . ﺍﻝﻘﻠﻁ ﻋﻠﻰ ﺍﻝﻤﻴﺎﻩ ﺍﻝﺠﻭﻓﻴﺔﻭﺍﺩﻱ ﺍﻷﺩﻭﻴﺔ ﺍﻝﺭﺌﻴﺴﻴﺔ ﻓﻲ ﻤﻨﻁﻘﺔ ﻤﺴﺘﺠﻤﻌﺎﺕ 
 ﺘﻡﻭ. ﺍﻻﻤﺘﺼﺎﺹ ﻭﺍﻝﺘﺤﻭل ﻝﺘﻠﻙ ﺍﻷﺩﻭﻴﺔ، ﻭﺍﻝﺘﻌﺭﻑ ﻋﻠﻰ ﺨﻁﻭﺭﺘﻬﺎ ﻋﻠﻰ ﺍﻝﺼﺤﺔ ﺍﻝﻌﺎﻤﺔﻝﻌﻤﻠﻴﺘﻲ 
 .ﺍﻝﻤﺭﻜﺒﺎﺕ ﺍﻝﺼﻴﺩﻻﻨﻴﺔﻭﺠﻭﺩ ﻫﺫﻩ ﻨﺴﺏ ﻓﻲ ﻝﻠﺘﺤﻘﻴﻕ  CLPHﻡ ﺘﺤﻠﻴل ﺍﺍﺴﺘﺨﺩ
ﻨﺤﻭ ﻐﻁﻲ ﻭﺍﻝﺫﻱ ﻴﺍﻝﻘﻠﻁ ﻓﻲ ﺍﻝﻀﻔﺔ ﺍﻝﻐﺭﺒﻴﺔ ﻋﻠﻰ ﺍﻝﺠﺎﻨﺏ ﺍﻝﻐﺭﺒﻲ ﻤﻥ ﻭﺍﺩﻱ ﺍﻷﺭﺩﻥ ﻭﺍﺩﻱ ﺴﺘﺠﻤﻊ ﻤﻴﻘﻊ 
ﺍﻝﻤﺴﺘﺠﻤﻊ ﺒﺎﻨﺤﺩﺍﺭ ﺸﺩﻴﺩ ﻴﺒﺩﺃ ﻤﺭﺘﻔﻌﺎﺕ ﺸﺩﻴﺩﺓ ﺍﻻﻨﺤﺩﺍﺭ ﻴﺒﻠﻎ ﺍﺭﺘﻔﺎﻋﻬﺎ ﻨﺤﻭ  ﻴﺘﻤﻴﺯﻜﻴﻠﻭﻤﺘﺭ ﻤﺭﺒﻊ،  371
ﻓﻲ ﺃﺴﻔل ﻤﺴﺘﻭﻯ ﺴﻁﺢ ﺍﻝﺒﺤﺭ  lsbm 052-ﺎ ﺩﻭﻥ ﻭﻴﺼل ﺇﻝﻰ ﻤﻓﻲ ﺍﻝﺠﺯﺀ ﺍﻝﻐﺭﺒﻲ  lsam 007ﺤﺩﻭﺩ 
ﻨﺴﻤﺔ ﻤﻥ ﺍﻝﺘﺠﻤﻌﺎﺕ ﺍﻝﺴﻜﺎﻨﻴﺔ ﺍﻝﻔﻠﺴﻁﻴﻨﻴﺔ  539,69ﺤﻭﺍﻝﻲ ﻭﻓﻲ ﻭﺍﺩﻱ ﺍﻝﻘﻠﻁ ﻴﺴﻜﻥ . ﺍﻝﺸﺭﻗﻲﺌﻪ ﺠﺯ
ﻤﻴﺎﻩ ﺍﻝﺼﺭﻑ ﻤﺘﺭ ﻤﻜﻌﺏ ﻤﻥ  000،41ﺘﺼﺭﻴﻑ ﺤﻭﺍﻝﻲ ﻭﻋﻠﻴﻪ ﻴﺘﻡ ، ﺍﻝﻤﺴﺘﻭﻁﻨﺎﺕ ﺍﻹﺴﺭﺍﺌﻴﻠﻴﺔﻭ
ﺃﺨﺭﻯ ﻤﻊ ﻤﻴﺎﻩ  ﻤﺭﺓﺎﺩﺓ ﺩﻤﺠﻬﺎ ﻭﻴﺘﻡ ﺇﻋ، ﻤﻥ ﻫﺫﻩ ﺍﻝﻜﻤﻴﺎﺕ ﻓﻘﻁ ٪03ﺤﻭﺍﻝﻲ ﻤﻌﺎﻝﺠﺔ ﻴﺘﻡ ، ﻭﺍﻝﺼﺤﻲ
 ﻤﻡ 006ﻴﻘﺩﺭ ﻤﻌﺩل ﻫﻁﻭل ﺍﻷﻤﻁﺎﺭ ﻓﻲ ﻭﺍﺩﻱ ﺍﻝﻘﻠﻁ ﻨﺤﻭ ﻋﻼﻭﺓ ﻋﻠﻰ ﺫﻝﻙ، . ﺍﻝﺼﺭﻑ ﺍﻝﺼﺤﻲ ﺍﻝﺨﺎﻡ
ﻓﻲ ﺍﻝﻤﻨﺎﻁﻕ ﺍﻝﺸﺭﻗﻴﺔ ﻤﻨﻪ، ﻭﻴﺒﻠﻎ ﻤﺘﻭﺴﻁ ﻜﻤﻴﺎﺕ ﻫﻁﻭل ﻤﻡ  051ﻓﻲ ﺍﻝﻤﻨﺎﻁﻕ ﺍﻝﻐﺭﺒﻴﺔ، ﻭﻻ ﻴﺯﻴﺩ ﻋﻥ 
ﻴﺔ ﺘﺩﻓﻕ ﺍﻝﻤﻴﺎﻩ ﻤﻥ ﺍﻝﻴﻨﺎﺒﻴﻊ ﻭﺘﺠﺩﺭ ﺍﻹﺸﺎﺭﺓ ﺇﻝﻰ ﺃﻥ ﻜﻤ. ﻤﻡ 004ﺍﻷﻤﻁﺎﺭ ﺍﻝﺴﻨﻭﻴﺔ ﻓﻲ ﺍﻝﻭﺍﺩﻱ ﻨﺤﻭ 
ﺩﻓﻕ ﺃﻤﺎ ﻜﻤﻴﺎﺕ ﺍﻝﻤﻴﺎﻩ ﺍﻝﺘﻲ ﺘﺘ، ﺴﻨﻭﻴﺎﹰ ﻤﻠﻴﻭﻥ ﻤﺘﺭ ﻤﻜﻌﺏ 21- 3ﻓﻲ ﺍﻝﻤﻨﻁﻘﺔ ﺘﺘﺭﺍﻭﺡ ﻤﺎ ﺒﻴﻥ  ﺓﺍﻝﻤﺘﻭﻓﺭ
  .ﺜﺎﻨﻴﺔ/ﻝﺘﺭ 003ﻓﻼ ﺘﺯﻴﺩ ﻋﻥ ﻤﺴﺘﻤﺭ ﺒﺸﻜل 
ﺒﺎﺴﺘﺨﺩﺍﻡ ﻁﺭﻴﻘﺔ ﻭﺫﻝﻙ  ﺩﻭﺍﺌﻴﺎﻤﺭﻜﺒﺎﹰ ﺴﺘﺔ ﻋﺸﺭ ﻨﺴﺏ ﻭﺠﻭﺩ ﺘﺤﻠﻴل ﻭﺭﻜﺯﺕ ﺍﻝﺩﺭﺍﺴﺔ ﺍﻝﺤﺎﻝﻴﺔ ﻋﻠﻰ 
 ,neforpoteK ,neforponeF ,neforpubI ,canifolciD ,nicahtemodnI ,nitecanehP: ، ﻭﻫﻲCLPH
 ,nipezamabraC ,eruäsnirbifolC ,tarbifazeB ,eruasnirbifoneF ,tarbifoneF ,lizorbifmeG
ﻭﺘﻭﺼﻠﺕ ﺍﻝﺩﺭﺍﺴﺔ ﺇﻝﻰ ﻭﺠﻭﺩ ﺜﻼﺜﺔ ﻤﺭﻜﺒﺎﺕ  .tarbifotE ,mapezaiD ,nexorpaN ,nillyfixotneP
ﻫﺫﻩ  ﻭﺘﻌﺩ .enpezamabraCﻭ  canifolciD، neforpubIﺒﺤﺙ ﻭﻫﻲ ﺒﻨﺴﺏ ﺘﺴﺘﺩﻋﻲ ﺍﻝﺩﺭﺍﺴﺔ ﻭﺍﻝ
 ﻓﻲ ﺍﻝﺼﻴﺩﻝﻴﺎﺕ ﻬﺎ، ﻭﻴﺘﻡ ﺘﺴﻭﻴﻘﺍﻝﻔﻠﺴﻁﻴﻨﻴﺔﻸﺩﻭﻴﺔ ﺍﻝﺘﻲ ﻴﺘﻡ ﺇﻁﻼﻗﻬﺎ ﻓﻲ ﺍﻝﺒﻴﺌﺔ ﻝﻤﺜﻠﺔ ﺍﻷ ﻤﻥ ﺃﺸﻬﺭ ﺍﻻﺩﻭﻴﺔ
ﺍﻝﻤﻴﺎﻩ ﻓﻲ  neforpubIﺘﻡ ﺍﻝﻜﺸﻑ ﻋﻥ ﻭ ﻺﻨﺴﺎﻥﻭﻝﺍﻝﻌﻴﺎﺩﺍﺕ ﺍﻝﺨﺎﺼﺔ ﻭﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﻝﻼﺴﺘﺨﺩﺍﻡ ﺍﻝﺒﻴﻁﺭﻱ ﻭ
 003ﻭﺒﺘﺭﻜﻴﺯ ﺒﻠﻎ ﺍﻷﻭﻝﻰ ﻭﺍﻝﺜﺎﻨﻴﺔﺍﻝﻌﻴﻨﺘﻴﻥ ﻓﻲ ﻓﻘﻁ  ﺔ ﻤﻌﺎﻝﺠﺔ ﺍﻝﻤﻴﺎﻩ ﺍﻝﻌﺎﺩﻤﺔ ﻓﻲ ﺍﻝﺒﻴﺭﺓﺍﻝﺩﺍﺨﻠﺔ ﺍﻝﻰ ﻤﺤﻁ
ﺍﻝﻌﻴﻨﺎﺕ ، ﻭﻝﻡ ﻴﺘﻡ ﺍﻝﺤﺼﻭل ﻋﻠﻰ ﺃﻴﺔ ﻨﺴﺏ ﻝﻪ ﻓﻲ ﻝﺘﺭ ﻋﻠﻰ ﺍﻝﺘﻭﺍﻝﻲ/ﻨﺎﻨﻭﻏﺭﺍﻡ 0001ﻝﺘﺭ ﻭ/ﻨﺎﻨﻭﻏﺭﺍﻡ
ﺘﻡ ﺍﻝﻜﺸﻑ ﻋﻥ ﻜﻤﺎ . ﻤﺤﻁﺔ ﻤﻌﺎﻝﺠﺔ ﺍﻝﻤﻴﺎﻩ ﺍﻝﻌﺎﺩﻤﺔ ﻓﻲ ﺍﻝﺒﻴﺭﺓ  ﻓﻲ ﺍﻝﺘﺨﻠﺹ ﻤﻨﻪﺍﻷﺨﺭﻯ ﻷﻨﻪ ﺘﻡ 
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ﻝﺘﺭ /ﻨﺎﻨﻭﻏﺭﺍﻡ 013ﻭﺒﺘﺭﻜﻴﺯ  ﺍﻝﺒﻴﺭﺓ ﺍﻝﻤﻴﺎﻩ ﺍﻝﻌﺎﺩﻤﺔ ﻓﻲ ﻤﻌﺎﻝﺠﺔ ﻤﺤﻁﺔﺍﻝﻤﻴﺎﻩ ﺍﻝﺩﺍﺨﻠﺔ ﺍﻝى ﻓﻲ canifolciD
ﻭﻗﺩ ﺍﻨﺨﻔﺽ ﻫﺫﺍ ﺍﻝﺘﺭﻜﻴﺯ . ﺎﺕﺨﺫ ﺍﻝﻌﻴﻨﻷﻲ ﺍﻝﺴﺎﻋﺔ ﺍﻝﺜﺎﻨﻴﺔ ﻝﺘﺭ ﻓ/ﻨﺎﻨﻭﻏﺭﺍﻡ 0541ﺍﻷﻭﻝﻰ ﻭﺍﻝﻌﻴﻨﺔ ﻓﻲ 
ﻓﻲ ﺍﻝﻤﺭﻜﺏ ﺜﻡ ﺍﺨﺘﻔﻰ . ﻋﻠﻰ ﺍﻝﺘﻭﺍﻝﻲﻝﺘﺭ /ﻨﺎﻨﻭﻏﺭﺍﻡ 522ﻭ ﻝﺘﺭ /ﻨﺎﻨﻭﻋﺭﺍﻡ 05ﻝﻴﺼل ﺇﻝﻰ ﺒﻌﺩ ﺍﻝﻌﻼﺝ 
ﻓﻲ  nipezamabraCﻤﺭﻜﺏ  ، ﺘﻡ ﺍﻝﻜﺸﻑ ﻋﻥﺠﻬﺔ ﺜﺎﻨﻴﺔﻤﻥ . ﻤﻨﻁﻘﺔ ﺍﻝﻤﺭﺸﺤﺎﺕﺭﺃﺱ ﺍﻝﻘﻠﻁ ﻭﻓﻲ 
 0571ﺼﺒﺢ ﻴﻝ ﺍﻝﺘﺭﻜﻴﺯ ﻭﻤﻥ ﺜﻡ ﺍﻨﺨﻔﺽﺍﻷﻭﻝﻰ  ﺍﻝﻌﻴﻨﺔﻝﺘﺭ ﻓﻲ /ﻨﺎﻨﻭﻏﺭﺍﻡ 5991 ﺒﻠﻎﺘﺭﻜﻴﺯ ﻭﺒ
ﻝﺘﺭ ﻓﻲ /ﻨﺎﻨﻭﻏﺭﺍﻡ 0551 ﺒﺘﺭﻜﻴﺯ، ﻭﺍﻝﺴﺎﺌﻠﺔﺒﻌﺩ ﻤﻨﻁﻘﺔ ﺍﻝﻤﻌﺎﻝﺠﺔ ﻀﻤﻥ ﻋﻴﻨﺎﺕ ﺍﻝﻨﻔﺎﻴﺎﺕ ﻝﺘﺭ /ﻨﺎﻨﻭﻏﺭﺍﻡ
ﻝﻠﻭﺼﻭل ﺇﻝﻰ ﻗﻴﻤﺔ ﺃﻗل  ﺍﻝﻘﻠﻁﺭﺃﺱ ﻤﻨﻁﻘﺔ ﻝﺘﺭ ﻓﻲ /ﻨﺎﻨﻭﻏﺭﺍﻡ 46ﻭﺒﺘﺭﻜﻴﺯ ﺒﻠﻎ ، ﻤﺨﻤﺎﺱ ﻭﺍﺩﻱﻨﻁﻘﺔ ﻤ
ﻝﻘﺩ ﻜﺸﻔﺕ ﺍﻝﻨﺘﺎﺌﺞ ﺃﻥ .ﻤﻨﻁﻘﺔ ﺍﻝﻤﺭﺸﺤﺎﺕ ﺍﻝﻤﻴﺎﻩ ﺍﻝﺩﺍﺨﻠﺔ ﻭﺍﻝﺨﺎﺭﺠﺔ ﻤﻥ ﻓﻲ ﺍﻝﻘﻴﻤﺔ ﺍﻝﻤﺴﻤﻭﺡ ﻭﺠﻭﺩﻫﺎ ﻤﻥ
ﻜﺎﻥ ﺃﻗل ﻤﻥ ﺍﻝﻘﻴﻤﺔ ﺍﻝﻤﺴﻤﻭﺡ ﻭﺠﻭﺩﻫﺎ ﻓﻲ ﺠﻤﻴﻊ  canefolciDﻭ ﺍل   neforpubIﺘﺭﻜﻴﺯ ﺍل 
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Chapter One 
Introduction 
 
1.1  Introduction                                                                                                
                            
Recently, the occurrence and the fate of pharmaceutically active compounds in the aquatic 
environment have been recognized as one of the prominent environmental issues that have 
been affecting the ecological system (Dietrich et al., 2005; Kotchen et al., 2009). 
Pharmaceutical compounds are any chemicals used for diagnosis, treatment, alteration or 
prevention of diseases (Thompson, 2005). Pharmaceutical products are used without taking 
into consideration their negative consequences on the environment in terms its high cost or 
effect. There are more than 100,000 types of chemicals are used in products and items 
either in households, industries or agriculture.  
 
Pharmaceutical pollution is considered as one of the most modern issues which may put 
the environment in jeopardy (Kummerer, 2004). Most of pharmaceutical products are 
slightly transformed or even unchanged forms are disposed from the bodies of humans and 
livestock in the form of fluids causing critical damage to the ecosystem. This issue is still 
in the early phases of development in Palestine, where our conventional wastewater 
treatment plants are not capable of removing pharmaceuticals completely as drinking water 
treatment plants are not made particularly for eliminating Pharmaceutically Active 
Compounds (PhACs).  
 
According to recent researches a variety of pharmaceuticals were identified in various 
water samples like health facilities of wastewater, pharmaceutical industries, wastewater 
treatment plant effluent, surface and ground water. Yu and his colleagues (2013) clarified 
the presence of some drugs in ground water and soil. Furthermore, drugs are poured down 
in sinks; flushed in the toilet, or disposed in the trash, without paying attention to their 
risks through landfills leachates that may reach to ground water (Yu et al., 2013). 
 
Although we need drugs for treatment of many diseases, it was found that they cause 
negative impacts on non-targets, environment, health and more. Therefore, negative 
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impacts can be mitigated through following scientific ways such as controlling random 
drugs used by the public, reducing distribution of physician free medical samples, sorting 
of solid waste, sewage recycling, upgrading sewage infrastructure, raising public 
awareness, nutrition and health maintenance, drug substitutes and research development. 
 
Many studies show trace concentrations of pharmaceuticals in wastewater, various water 
sources and some drinking-waters. One these studies conducted by Andreozzi and his 
colleagues (2003) argues that the presence of humic substances hindered 
phototransformation of Diclofenac and Carbamazepine while nitrate enhanced the 
phototransformation rate of these compounds. Although, of the positive effect of 
phototransformation in the environment for reducing drug levels it can lead to formation of 
transformation product which are more stable and toxic than the parent compounds, e.g. 
the carcinogenic acridine is formed during phototransformation of Carbamazepine (Chiron 
et al., 2006). 
 
In Palestine and Jordan, Marei and Tiehm (2007) studied the occurrence of 
pharmaceuticals in certain sites. The findings showed that target compounds of (Ibuprofen, 
Diclofinac and Carbamazepine) exist in an unneglegable amounts where it laid in the last 
resorts of wastewater catchment areas. 
Locally, Diclofinac and Ibuprofen are used in pharmaceutical manufacturing products for 
human and veterinary sector, except Carbamazepine which is exclusively used for human, 
whether used through physician prescription or by the person himself. This is clear from 
my reviews to the Palestinian Ministry of Health data and many pharmacies. Regarding to 
the above mentioned reasons, this study will investigate the fate of some pharmaceuticals 
compounds (Phenacetin, Indomethacin, Diclofinac, Ibuprofen, Fenoprofen, Ketoprofen, 
Gemfibrozil, Fenofibrat, Fenofibrinsaure, Bezafibrat, Clofibrinsäure, Carbamazepin, 
Pentoxifyllin, Naproxen, Diazepam, Etofibrat), mainly Ibuprofen, Diclofinac sodium and 
Carbamazepine in drinking water. 
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1.2. Objectives                                                                                                    
                            
This research aiming at understanding the occurrences, fate and the transportation of some 
pharmaceuticals compounds (Phenacetin, Indomethacin, Diclofinac, Ibuprofen, 
Fenoprofen, Ketoprofen, Gemfibrozil, Fenofibrat, Fenofibrinsaure, Bezafibrat, 
Clofibrinsäure, Carbamazepin, Pentoxifyllin, Naproxen, Diazepam, Etofibrat), mainly 
Ibuprofen, Diclofinac sodium and Carbamazepine at wadi Al-Qilt catchment, and to 
identify their risk on public health and environment. 
The specific objectives are: 
1. To investigate the presence and measure the concentration of Phenacetin, 
Indomethacin, Diclofinac, Ibuprofen, Fenoprofen, Ketoprofen, Gemfibrozil, 
Fenofibrat, Fenofibrinsaure, Bezafibrat, Clofibrinsäure, Carbamazepin, 
Pentoxifyllin, Naproxen, Diazepam, Etofibrat in the wadis – mainly sewage waters-
, springs ground waters, Jericho water treatment plant that supply drinking water to 
Aqbat-Jabr refugee camp.    
2. To know the fate of the three main pharmaceuticals (Ibuprofen, Diclofinac and 
Carbamazepine) in Al Qilt cacthment area. 
3. To identify the risk of these pharmaceuticals on public health.                                                                           
1.3. Justification                                                                                                 
                            
In Palestine, there are many factories that manufacture pharmaceuticals, in addition to the 
existence of many governmental and specialized hospitals, where a lot of their wastes 
contain (Ibuprofen, Diclofinac and Carbamazepine) among others that have been thrown 
out in the environment. Despite the existence of these wastes in small quantities, long term 
disposure of them may result in significant environmental concentrations and consider 
being one of the most dangerous contaminant for the Palestinian environment (Alshouli, 
2012).  
Pharmaceuticals and PPCPs exist in Palestine via hospitals and drugs manufacture 
factories, where these compounds have been thrown as disposals in residential wastewater.  
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The findings of many researches showed that about (85%) of it portray the main source of 
influent to the plant. Since there is target PPCPs: Carbamazepine, Ibuprofen and Diclofinac 
may be found in septic tanks and consequently groundwater due to incomplete human 
metabolism and excretion into the waste stream or by disposal of unused medication in the 
toilet or down to sink, and not be completely removed during the wastewater treatment 
process, these compounds may be discharged into streams and land application sites, and 
therefore contaminate aquatic environment or persist in surface water, groundwater, and 
soil (Karnjanapiboonwong, 2010). 
Carbamazepine (CBZ) has been frequently detected in study area among other active 
pharmaceutical ingredients (API) that has been used in relatively high volumes. 
Carbamazepine is a pharmaceutically active compound along with its metabolite 
Carbamazepine N-glucuronide while Carbamazepine-diol is not. 
This study focused on sixteen pharmaceuticals that will be determined but three were 
found with significant concentrations: Ibuprofen, Diclofinac (non steroidal anti-
inflammatory drugs (NSAIDs)) and its metabolites, and Carbamazepine because of their 
high consumption in Palestine, these pharmaceuticals are marketed in the Palestinian 
market (pharmacies). 
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Chapter Two 
Literature review 
2.1 Introduction                                                                                                 
                            
Palestine suffers from shortage of mineral water resources (streams, rivers), and water 
deteriorations of natural resources due to human activities. These activities include 
domestic or industrial wastewater, stone cutting, arbitrary dumping sites and urban runoff. 
These activities emit pollutants that reach to the nearest wadis. In West Bank, there are 
about 363 disposal sites to discharge these raw wastewater into the environment (ARIJ, 
1999a), eight of them are located in wadi Al-Qilt catchment. The problem increases when 
people transform their septic tank by trucks into wadis, where it will also be mixed with 
urban run off during winter season. In wadi Al-Qilt catchment area there are 65,935 
Palestinian people inhibit from cities, communities and refugee camps who live in West 
Bank, in addition to nearly 6,000 people who are living in Eastern Jerusalem. Furthermore, 
there are six settlement colonies estimated by 15,000 settlers living in the same area 
(PCBS, 2003).   
Generally, weakness and ignorance of concern toward water treatment projects are noticed, 
for example RIJA argued that 30% of wastewater discharged in West Bank is treated 
efficiently, and 70% of the generated wastewater is discharged untreated to the 
environment 30% of total waste water which equals to 5,000 m3/d is treated at Al-Bireh 
treatment station, but they remixed with raw wastewater from Qalandiah and Al-Ram with 
3,000 m3/d, all quantities continue running to downstream until eliminated completely 
(ARIJ, 2007). 
 
The study will focus on pharmaceutical compounds that may found in A-Qilt catchment. It 
is worth mentioning that at this catchment area, there is only one pharmaceutical company 
(Al-Quds Pharmaceutical Company), where it disposes its medical waste in special ways, it 
uses ISO 14001 SYSTEM before they reach wastewater treatment system, that means 
medical waste is not the main source of pharmaceutical pollutant in the chosen wadi. 
 
Wadi Al-Qilt is the main system in the area, its catchment area extends from Jerusalem and 
Ramallah in the west towards Jordan River in the east. The system of wadi Al-Qilt springs 
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is the main water source for filtration station(Al murashahat) where water transports from 
springs to the treatment facility through a 13km long open transportation canal. Al 
murashahat  applying slow sand filters system and a chlorination unit is located in Aqbat-
Jabr refugee camp which serves nearly 5,000 inhabitants. Sand filter beds at Almurashahat 
was covered with algal growth and there  was an increase in the turbidity of treated effluent 
during storm weather flow. 
The study conducted to provide information about wadi Al-Qilt drainage basin including 
types and possible sources of pharmaceuticals that may present in it. In order to investigate 
the presence of pharmaceuticals in wadi Al-Qilt catchment area, sampling stations were 
assigned along the path of the wadis, starting from Al-Bireh Wastewater Treatment Plant 
(AWWTP) path of the wadis starting to Al Murashahat  inlet. 
The most API that has been used in relatively high volumes and which has been frequently 
detected in the study area is Carbamazepine (CBZ).  
In this study, many pharmaceuticals has been determined, measured and screened, where 
three of them have significant concentrations, Ibuprofen, Diclofinac (NSAIDs) and its 
metabolites, and Carbamazepine (anticonvulsant), where these pharmaceutical compounds 
consumed higher than others in Palestine and marketed in the Palestinian market 
(pharmacies) among others (Ministry of Health, 2013).  
2.2 Definition of Non Steroidal Anti-Inflammatory Drugs (NSAIDs)          
                            
  
Non Steroidal Anti-Inflammatory Drugs (NSAIDs), are drugs with analgesic, antipyretic, 
and, in higher doses, with anti-inflammatory effects. The most common members of 
NSAIDs are Aspirin, Diclofenac, Ibuprofen, and Naproxen partly because they are 
available over-the-counter (OTC) drugs in many countries (Warden, 2010). 
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2.2.1 Ibuprofen 
2.2.1.1 Definition 
Ibuprofen is considered as one of common consumable global NSAIDs, with analgesic and 
antipyretic properties, which is an ionic acid derivative (Jacobs et al., 2011). It is the most 
consumed drug from the classification of the NSAIDs, where patients consume more than 
70 million annual prescriptions in the world (Mendoza-Arriaga et al., 2010). 
 
Ibuprofen is a pulp medicine in the World Health Organization (WHO), have an anti- 
platelet effect, though it is relatively mild and short-lived when compared with  other  anti 
platelet drugs. Half-life of Ibuprofen is (1.9-2.2) hours, with a molecular weight = 206.281 
g/mol (Jarrar, 2003). In many areas, Ibuprofen trade names include (as Brufen, Motrin, 
Nurofen, Advil, and Nuprin). Figure (2.1) shows the chemical structure of ibuprofen. 
 
Figure 2.1: Chemical structure of ibuprofen 
2.2.1.2 History of Ibuprofen 
Ibuprofen was discovered in 1961 by Andrew RM Dunlop, and his colleagues as a form of 
propionic acid . It was developed at the Boots Company in the 1960s in the UK. The 
discovery was registered  1961. Ibuprofen was made available under prescription in 1969, 
while it  had been approved in United States in 1974 (Rang et al., 1995). 
 
 
 
 
 
 
8 
 
2.2.1.3 Mode of Action 
Ibuprofen is acting as  inhibitor  of both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 
(COX-2) enzymes which leads to the inhibition of prostaglandin synthesis, which leads to    
analgesic and anti-inflammatory action of the drug (Rang et al.,1995). 
2.2.1.4 Pharmacokinetics: 
The absorbtion of ibuprofen occurr in gastrointestinal. It is extremely surrounded (90-99%) 
to plasma proteins and is largely metabolized to inactive compounds in the liver (mainly by 
glucuronidation). The rapid and full excretion of the inactive metabolites and a low  
amount of unchanged Ibuprofen occur by the kidney, with elimination of 95% of the 
administered dose in the urine during four hours of ingestion (Rang et al., 1995). 
2.2.1.5 Medical Uses of Ibuprofen 
In his study, Jarre  mention that Ibuprofen is  the most common NSAIDs, which used for 
both human and veterinary purposes . It  used for the treatment of headaches, muscle 
aches, back aches, dental pain, menstrual cramps and arthritis.also  Ibuprofen reduces fever 
and relieves minor aches and pain due to the common cold or flu, by the enzyme in the 
body that makes prostaglandins, and decreasing prostaglandins helps to reduce pain, 
swelling, and fever (Jarrar, 2003). 
2.2.1.6 Ibuprofen Interactions 
Matthieu shows that Ibuprofen can interact with an anticoagulants (including 
Warfarin),which  increase risk of severe bleeding to fatal hemorrhage from the 
gastrointestinal tract. more over, it reduces the anti-hypertensive effect of beta-blockers 
and diuretics and this causes hyperkalemia in patientsv (Matthieu, 1992). Ibuprofen may 
increase bleeding time in patients treated with Zidovudine, and may also interact with 
probenecid, antidiabetic medicines and phenytoin (Hersh et al., 2007). 
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2.2.1.7 Side Effects of Ibuprofen 
The Adverse effects of Ibuprofen are rare (with non-prescription or short-term use of 
Ibuprofen), they may include (Al-Nasser, 2000): 
• Gastrointestinal (heartburn, dyspepsia, loss of appetite, nausea, diarrhea and 
stomach pain), 
• Central nervous system (CNS) (fatigue, dizziness, nervousness and headache), 
• Hypersensitivity reactions (itching and skin rashes). Dermatitis and epidermal 
necrolysis have been reported with Ibuprofen, but very rarely, 
• Photosensitivity (very rare cases), 
• Cardiovascular (fluid retention and in some cases oedema) (rare effects at non-
prescription doses), 
• Allergic reactions (like itching, skin rash, swelling of the face, breathing 
difficulties). 
2.2.1.8 Ibuprofen Effects on Ecosystem  
The main route of ibuprofen entering surface waters is from wastewater treatment plant 
effluent, although a significant portion of ibuprofen is degraded in wastewater treatment 
(Buser et al., 1999). Ibuprofen metabolites include hydroxy and carboxyibuprofen. Studies 
if Ibuprofen effect on aquatic life, like water plant called duckweed, Lemna minor,  
showed a declined ability to grow in an exponential decreasing manner. The effects on 
Lemna have been the most severe recorded to date. In a small ecosystem the loss of one 
organism could mean disaster to the whole food chain. With respect to human beings, there 
is an increasing concern as of prolonged use of ibuprofen, as it might cause 
gastrointestinal, cardiovascular, kidney, and brain conditions( Sirocki et al., 2013). 
2.2.3Diclofenac 
2.2.3.1 Definition 
 
Diclofenac sodium is phenyl acetic acid derivative. It is used as anti-inflammatory, 
analgesic and antipyretic for human and veterinarian treatment. The proper dose is 1.4 
L/Kg. It  surrounds to human serum proteins as per 99% . It spread into and out of synovial 
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fluid. Their removal occurr through urinary and biliary excretion of the glucuronide and 
the sulphate conjugates of the metabolite (Todd and Sorken, 2007). 
 
Diclofenac act like anti-microbial drug and is under investigation for the treatment of 
tuberculosis. Diclofenac sodium is applied for pain relief in osteoarthritis, rheumatoid 
arthritis , ankylosing spondylitis and often used to treat chronic pain associated with 
cancer. When Diclofinac was taken in small doses daily there is an inhibition of the 
development of Alzheimer disease. It also acts as anti-uricosuric agent. Diclofenac is one 
of the most used drug, it was one of the first PhAc that could be detected in the aquatic 
environment (Buser et al., 1998). 
Figure (2.2) shows the chemical structure of Diclofenac. 
 
 
Figure 2.2: Chemical structure of Diclofenac 
 
2.2.3.2 History of Diclofenac 
The name "Diclofenac" derives from its chemical name: 2-(2,6dichloroanilino)   
 phenylaceticacid. Ciba-Geigy (now Novartis) advances  Diclofinac in 1973. It was first 
introduced in the UK in 1979. The usage of Diclofinac may be as sodium or potassium salt. 
Diclofinac is common drug and has a number of formulations..  The approval of OTC use 
is found in some countries for minor aches and pains and fever associated with common 
infections (Salmann, 1986). 
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2.2.3.3 Mode of action 
Its action is similar to any NSAIDs. The Diclofinac acting as inhibition the enzyme, 
cyclooxygenase (COX), an early component of the arachidonic acid cascade, resulting in 
the reduced formation of prostaglandins, thromboxanes and prostacylin (McGettigan et al., 
2013). 
2.2.3.4  Pharmacokinetics 
The pharmacokinetics describes the absorption, metabolism, and excretion processes 
occurring in the body after the drug is administered. The kidneys and liver generally 
eliminate substances from the body, and data on the pharmacokinetics of diclofenac 
provides details as to which organ assumes primary responsibility for excretion and what 
medical conditions may hinder the process (Rahal et al., 2008). Once absorbed, the body 
metabolizes, or breaks down the compound into metabolites and conjugates. These 
substances generally bind to proteins, particularly albumin. Through a diffusion process, 
diclofenac enters tissues that contain little to none of the drug. When tissue levels of the 
medication exceed levels in the bloodstream or the extracellular spaces, proteins carry the 
medication out of the tissues (KE and NM, 1997). 
2.2.3.5 Medical use 
Diclofinac is used for the treatment of pain, inflammatory disorders (musculoskeletal 
complaints, especially arthritis, rheumatoid arthritis, polymyositis, dermatomyositis, 
osteoarthritis, dental pain, TMJ pain,  spondylarthritis, ankylosing spondylitis, gout attacks 
and pain management in cases of kidney stone sand gallstones), dysmenorrheal, and 
additional indication in the treatment of acute migraines. Diclofinac is used commonly to 
treat mild to moderate postoperative or post-traumatic pain, in particular when 
inflammation is also present, and is effective against menstrual pain and sendometriosis 
menstrual (Prasanna and Chandrashekar, 2010). 
Diclofinac medicinal sample (eye drops: Voltaren-ophtha) are sold to treat acute and 
chronic nonbacterial inflammations of the anterior part of the eyes (e.g., postoperative 
states) . 
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2.2.3.6 Interactions 
McGettigan and his colleagues clarify the mechanism of action of Diclofenac sodium is as 
same as other NSAIDs. it affects the enzyme, cyclooxygenase (COX), an early component 
of the arachidonic acid cascade by inhibition, leading to the reduced formation of 
prostaglandins, thromboxanes and prostacyclin. in other hand,McGettigan and his 
colleagues say: It is not completely understood how reduced synthesis of these compounds 
results in therapeutic efficacy (McGettigan et al., 2013). 
2.2.3.7.Side effects 
A serious side effect of Diclofinac such as (Solomon et al., 2006): 
• Gastro Intestinal complications 
• weight gain, swelling in some organs like tongue urinating less than usual or not at 
all; 
• jaundice (yellowing of the skin or eyes); 
• Bruising, severe tingling, numbness, pain, muscle weakness; 
• Neck stiffness, chills, and/or seizure (convulsions) 
• Severe skin reaction- fever 
 
2.2.3.8 Diclofenac effect  on ecosystem 
 
Diclofinac is poorly removed in treatment plants and thus is found in the effluents, and 
enters water bodies. In general Diclofenac is a pharmaceutical that entering aquatic 
environment and must be considered harmful for the ecosystem and there necessary to 
evaluate the occurrence of the parent compound and transformation products, as well as 
their ecotoxicological effect. Diclofinac is easily undergo phototransformation reactions in 
the environment and it is toxic to some vulture species. Diclofenac can be taken by fish 
with a concentration of (1µg\L) in the environment. Moreover, many studies have been 
shown that Diclofenac  undergoes bioconcentration in fish (Hoeger, 2005). 
 
 
2.2.4 Carbamazepine  
2.2.4.1 Definition 
Carbamazepine is an antiepileptic drug used to control seizures
anthropogenic marker in water bodies, and its major human metabolites, Carbamazepine 
diol (CBZ-DiOH) and Carbamazepine
Malarvizhi et al., 2012). 
 
Figure (2.3) shows the chemical structure of Carbamazepine.
Figure 2.3: 
2.2.4.2 History of Carbamazepine
Carbamazepineat was discovered by 
Switzerland, in 1953 before its anti
synthesized drug in 1960
trigeminal neuralgia (known as tic douloureux formerly )
an anticonvulsant in 1962
Carbamazepine has approved in the USA
Carbamazepine to control mania in patients refractory to antipsychotics
  
2.2.4.3 Mode of Action      
The stabilizing of the inactivated state of Voltage
which makes little of these channels 
excitable until the drug dissociates. Carbamazepine has also been shown to potentiate 
GABA receptors made up of alpha1, beta2, gamma2 subunits. This may be relevant to its 
activity in neuropathic pain and manic
13 
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 N-glucuronide (CBZ-N-Glu) (Zwiener
 
 
Chemical structure of Carbamazepine 
  
chemist Walter Schindler J.R. Geigy AG in Basel, 
-epileptic properties had been discovered. Schindler
. Firstly, Carbamazepine was marketed as a drug to treat 
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. Drs. Hanaoka and Takezaki first used 
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-depressive illness (Granger et al., 1995).
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 et al., 2003; 
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 caused by CBZ 
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2.2.4.4  Pharmacokinetics 
Gastrointestinal tract is the site where Carbamazepine (CBZ) completely absorbed with the 
major amount  of the dose being found in the urine (Table 2.1). The slow rate of excretion 
occur in the feces. Carbamazepine is also extensively metabolized in the body, as after oral 
administration 72% of it was found in the urine and 28% in the feces (Faigle and Feldman, 
1976). Only 17% of the total usage of CBZ would be expected to enter the environment as 
CBZ, with 34% entering as the CBZ-DiOH or the O-glucuronide of CBZ-DiOH. The 
major metabolic pathways of CBZ are shown in Figure (2.4) (Faigle and Feldman , 1976). 
 
Figure 2.4: Carbamazepine metabolism (Zhang et al., 2008) 
 Biotransformation of CBZ via epoxidation and glucuronidation (I – CBZ; II – CBZ-EP; III 
– CBZ-N-Glu; IV – minor mono-hydroxy derivative of CBZ; V – CBZ-DiOH) (Faigle and 
Feldman, 1976). 
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2.2.4.5 Medical uses of Carbamazepine 
Carbamazepine is used for the treatment of seizure disorders and neuropathic pain. Also it 
used as a second line treatment for bipolar disorder and along with antipsychotic agents in 
schizophrenia. In the United States, the FDA-approved indications 
are epilepsy (including partial seizures and tonic-clonic seizures), trigeminal neuralgia, and 
manic and mixed episodes of bipolar I disorder (Paul et al., 2011). 
Carbamazepine has an effective and safe applications as lithium for the treatment of 
bipolar disorder, both in the acute and maintenance phases (Ceron-Litvak et al., 2009). 
2.2.4.6 Interactions 
Carbamazepine interacts with multiple drugs and warning should be used in joining  other 
medicines with it. When  phenobarbital, phenytoin (Dilantin), or primidone (Mysoline) 
then Lower levels of it is seen.  Warfarin (Coumadin), phenytoin (Dilantin), theophylline, 
and valproic acid (Depakote, Depakote ER, Depakene, Depacon) were administrated with 
Carbamazepine there is a rapid metabolization occurr, while carbamazepine levels are 
increased when taken with erythromycin,cimetidine (Tagamet), propoxyphene (Darvon), 
and calcium channel blockers. The metabolism (destruction) of the hormones in birth 
control pills as well is increase by Carbamazepine  and the effectiveness of birth control 
pills can be reduced because of it. Unexpected pregnancies have occurred in patients taking 
both carbamazepine and birth control pills. Concerning to Carbamazepine food interaction, 
grapefruit juice raises the bioavailability of Carbamazepine by inhibiting CYP3A4 
enzymes in the gut wall and in the liver (Faigle et al., 1976). 
 
2.2.4.7 Side Effects of Carbamazepine                                                            
                            
                                          Common side effects caused by Carbamazepine may include:     
                                   
• Water retention, swelling, or difficulty breathing, which can be signs of CHF, 
• High blood pressure (hypertension) or low blood pressure (hypotension), 
• An irregular heart rhythm (arrhythmia), 
• Yellowing of the whites of the eyes or skin (jaundice), which may be a sign of liver 
damage, including liver failure or hepatitis, 
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• Difficulty passing urine or a sudden, unexplained decrease in urine production 
(which can be a sign of kidney damage) (Diener et al., 1997) 
• Low sodium levels in the blood (hyponatremia), which may cause symptoms such 
as: Loss of appetite, nausea or vomiting, irritability, ixcessive tiredness, confusion 
hallucinations, muscle weakness. 
2.2.4.8 Carbamazepine Effects on Ecosystem 
CBZ is considered as an anthropogenic marker of urban contamination because of its 
persistence (about 100 days) in effluent and surface waters ( Clara et al., 2004 and Gagne 
et al., 2006). The most influenced animals by CBZ are small animals like fish and other 
invertebrate like (Mytilus galloprovincialis) (Ramesh et al., 2012).  
The exposure of fish to environmental pollutants show a variety of physiological 
responses, including affectation of blood balance, ion regulatory capacity and uptake and 
its relative transport of oxygen (Booth et al., 1988). The physical, chemical and 
pharmacological properties of Carbamazepine and Diclofinac are summarized in Table 
(2.1). 
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Table 2.1: Physical, chemical and pharmacological properties of Carbamazepine 
and Diclofinac (Zhang et al., 2008 ) 
 Carbamazepine (CBZ) Diclofinac (DFC) 
Pharmacology 
Structure, 
formula, CAS 
No. and 
molecular weight 
 
 
C15H12N2O C14H11Cl2NO2 
298-46-4 15307-86-5 
236.27 g mol−1 296.16 g mol−1 
Usage Analgesic, antiepileptic Analgesic, anti-inflammatory 
Water solubility 17.7 mg L−1 (25 °C) 23.73 mg L−1 (25 °C) 
Log P (octanol–
water)  
2.45 – 
Henry’s Law 
Constant 
1.09 × 10−5 Pa m3 mol−1 (25 °C) 4.79×10−7 Pa m3 mol−1 (25 °C) 
pKa Neutral 4.15a 
Elimination half-
life 
25–65 h 2 h 
Excretion 72% of oral dosage excreted in urine, 
28% in faeces 
Biliary excretion: 65% of oral dosage 
excreted in urine 
Metabolites in 
urine (%of oral 
dosage) 
CBZ, CBZ-epoxide, CBZ-diol, CBZ-
acridan, 2-OH-CBZ, 3-OH-CBZ 
DFC, 5-OH-DFC, 4′-OH-DFC, 3′-OH-
DFC, 4′-5-diOH-DFC, 4′-OH-5-Cl-
DFC, 3′-OH-4′-CH3O-DFC 
Dosage Maintenance usually 800–1200 mg 
daily. 
75–150 mg daily 
Other 
Information 
Autoinduction, i.e., long term 
applications increase its metabolism 
Dermal applications available 
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2.3 Source of Pharmaceutical in Environment                                               
                            
In spite of all benefits of these drugs in the treatment of many diseases for human and 
animals, but the added to the environment in large quantities, through several sources that 
include (Moreno-González et al., 2014): 
- Direct disposal at manufacturing. 
- Excretion with urine and feces (wastewater). 
- Drugs in animal manure. 
Industrial wastewater may be possible source for contamination of surface water. The 
following figure (2.5) shows routes of the pharmaceuticals entering to the environment: 
 
Figure 2.5: Drug flow Pharmaceuticals and their metabolites enter environment from 
homes, health care facilities, and farms (Halford, 2008) 
The pharmaceutical administrated (consumed) by human after required action in the body 
get excreted with urine and feces as original compound, and usually as a number of 
metabolites. The environmental concerns stems because these Pharmaceuticals are not 
always adequately destroyed in the wastewater treatment plants (Dietrich et al., 2005), 
consequently they enter the surface water where they may affect aquatic life (Katarzyna et 
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al., 2007).Moreover, drinking water treatment plants are not specifically designed to 
remove PhAcs. 
2.4 Removal in WWTP                                                                                     
                            
The elimination of pharmaceutical compounds occurs in WWTPs in different mechanisms. 
The phototransformation is the important process which is used microorganism to 
mineralize pharmaceutical compounds into water and carbon dioxide, or degrade them into 
inactive form. As WWT process occur in open air, wastewater are exposed to sun light. In 
general, pollutants will be removed from water by stripping into air or by sorption onto 
sludge that is regularly discharged. 
In Palestine, the WWTP use activated sludge processes.These processes do not remove 
pharmaceutical Compounds completely. Marie and Tiehm (2007) studied the emerging 
pollutants elimination processes applying membrane bioreactor and combination of MBR 
and Powdered Activated Carbon (PAC) technique and gained the following results in 
Table (2.2). 
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Table 2.2: Degree of elimination of four pharmaceutical substances (Bezafibrate, 
Carbamazepine, Ibuprofen, Diclofinac) by batch and column mechanism (Marei and 
Tiehm, 2007) 
 Elimination according to 
Marei and Tiehm study.  
Elimination in Literature 
Substance Batch 
(effluent) 
Column 
(20º) 
observed  not observed 
Bezafibrate + + + + + + Joss et al.(2006); 
Quintana et 
al.(2005) 
 
\ 
Carbamazepine - +  
\ 
Clara et al.(2004); 
Schyett et 
al.(2006) 
Ibuprofen + + + + + + Joss et al.(2006); 
Zwiener et al 
.(2000); Smook et 
al.(2008) 
 
\ 
Diclofinac + + + + + Gonzalez et 
al.(2006) 
Joss et al.(2006); 
Quintana et 
al.(2005) 
*- no removl, + removal<50%, ++ removal 50_90%, +++ removal>90% 
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2.5 General description of Wadi Al Qilt drainage basin Study area            
                            
 
Study area of Wadi Al Qilt is illustrated in Figure (2.6). 
 
Figure 2.6: Al Qilt catchment area 
 
2.5.1 Study area location                
The study area is Wadi Al-Qilt cachment area (AWWTP, Mikhmas bridge, Al Qilt spring, 
Al Murashahat in aqpat jaber). Wadi Al-Qilt is situated in the east of the West Bank, 
including part of Ramallah, Al Bireh, Jerusalem and slopes down to Jericho with an area of 
174 Km2 (ARIJ, 2007). 
Ras-Al Qilt  
Mukhmas
Qalandia
Al bireh  
Murashahat  
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2.5.2 Metrological Data 
2.5.2.1 Population 
Palestinian population living in the Wadi Al Qilt basin were  estimated to be about 97,000 
inhabitant (Al Bireh City (38200), Kafr O’qb (10000), Qalandia Camp (8800), Borqa 
(2240), Jaba’ (3140), Mikhmas (1820), Al-Ram (24840), Hizma (5920), Anata (9340) and 
Beit Hanina(1345)).  
2.5.2.3 Climate 
The West bank is dominated by the Mediterranean climate with distinctive four seasons, 
with short wet period and longer dry period. 
2.5.2.4 Rainfall 
In Al-Qilt, the average rainfall over the catchment area is about 400 mm/year (PWA, 
2009).  
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Chapter Three 
Methodology 
 
3.1 Personal communications and interviews                                                 
                            
Meetings and personal communications with employee from the Palestinian Water 
Authority (PWA), some employee who work in the ministry of health and in the Jerusalem 
pharmaceutical company. The goal of this meetings was to renew the data, to identify other 
issues with the water resources that are not mentioned in the literature, as well as to collect 
data about the status of the pharmaceuticals in the study area.  
3.2 Field Work                                                                                                   
                            
Field work and field surveys were basic modules in each aspect of this study, essentially to 
assure the data collected during the interviews, to know the existing water resources, 
limiting sampling stations and water sampling. Field visits were done to the study area. at 
November 2013 and April 2013. Because of the continual flow of water through wadis 
from AWWTP to water filtration plant(Al Murashahat), sampling stations were limited 
through Wadi Al Qilt, begining from AWWTP effluent (as it constitute the beginig flow in 
the drainage area), going through Wadi Al Qilt, ending with the effluent of Al Murashahat. 
Sampling frequency was variable according to the weather status. 
3.3 Sampling Time and Site                                                                              
                            
Samples were collected at two different times in  November 2012 during one days during 
wet weather in winter and the samples were collected again in April 2013 from the same 
stations and analyzed to make sure of the first result. 5 water samples were taken, from 
four stations (AWWTP, Mukhmas bridge, Al Qilt spring, Al Murashahat in Aqpat Jaber) 
(Figure 3.1). Distance between sampling stations (Figure 3.2). 
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Figure 3.1: Wastewater sampling locations in Al-Qilt catchment 
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Figure 3.2:Distance between sampling stations 
3.4 Field analysis and wet chemistry                                                               
                            
The physical chemo-physical parameters such as electrical conductivity, total dissolved 
solid, pH and temperature were measured with suitable instruments at the field. Collecting 
data and the visit has been shown in Figure (3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Measuring physical parameters in the water samples  
(pH, Temperature and TDS) 
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3.5 Samples Collection                                                                                      
                              
The procedure for sample collection is critical so there is no difference in sample 
collection, which will lead to sample analysis. Below is a description of some important 
factors of sample collection to be concerned. 
3.6 Samples Bottles                                                                                            
                             
The samples were collected in HDPE bottles. These bottles are impact resistant, and 
provide a good moisture barrier. Sample bottles were filled and nearly 1 inch left empty of 
bottle rim. This will leave an air space in the sample bottle to allow for mixing of the 
sample in the laboratory. 
3.7 Sample Volume                                                                                            
                             
500 mL of sample is enough to be extracted through a SPE cartridge. Sample analysis 
include duplicates. Which need two separate sample bottles to evaluate sample collection 
reproducibility.  
3.8 Preservative                                                                                                  
                             
A preservative should be used to prevent the decomposition for the analyte of interest. The 
samples were preserved using concentrated hydrochloric acid 4% to stop microbial 
activity.        
3.9 Filtration                                                                                                       
                              
Filtration is important after sample collection to prevent bacterial growth. If the sample is 
not more turbid and filtration may decrease analyte recovery and, sample filtration was not 
applied. Instead, samples were analyzed within seven days, and samples were left to settle 
any particles (if any) for one hour before sample extraction. 
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3.10 Sample Storage                                                                                          
                             
Samples were stored at 4ºC. The water samples should not be frozen during storage 
however should be cold enough to deter any algae formation or bacterial growth. Samples 
should also be away from excessive sunlight. 
3.11 Water Analysis                                                                                           
                            
The aim of water analysis was made to define the level of pharmaceutical pollution of 
water flux in wadi Al Qilt. This was achieved through measuring the following 
pharmaceutical compounds Phenacetin, Indomethacin, Diclofinac, Ibuprofen, Fenoprofen, 
Ketoprofen, Gemfibrozil, Fenofibrat, Fenofibrinsaure, Bezafibrat, Clofibrinsäure, 
Carbamazepin, Pentoxifyllin, Naproxen, Diazepam, Etofibrat using High Performance 
Liquid Chromatography (HPLC) in Water Research Center (UFZ), Magdeburg, Germany. 
Samples were acidified and preserved at 4ºC after collection until the analysis. 
All compounds were pre-concentrated applying solid phase extraction (SPE) and analyzed 
by HPLC coupled with tandem spectrometry (MS/MS). SPE has an advantages which is 
relatively less solvent is used;  suitable operation and good reproducibility (Laven et al., 
2009). The pH of the samples was adjusted in the lab at extraction day. Before SPE 
conformable internal standards  for all analytes were spiked into the samples and used for 
quantification. Limits of quantification (LOQ) were 10 ng L-1 in all case.  
Cartridges were eluted with 10 mL acetone. After extraction, the elute was evaporated until 
dry and reforming with 50 mL methanol followed by 50 mL ultra pure water. The 
compounds were isolated by an Agilent 1100 HPLC (Agilent Technologies, Waldbronn, 
Germany) on a Luna C18 column (250 mm - 2 mm; 5 mm) (Phenomenex, Aschaffenburg, 
Germany). An API 2000 mass spectrometer (AB Sciex, Foster City, USA) was used for 
detection and quantification of CBZ (Lange et al., 2011). 
Samples analysis based on Water and Wastewater Standard Methods (APHA, 2000), and 
based on "Deutsche Einheitsverfahren zur Wasser-, Abwasser- und 
Schlammuntersuchung". Specefic methods applied by the Water Research Center (UFZ), 
Magdeburg, Germany. 
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Chapter Four 
Results and Discussion 
 
4.1 General                                                                                                         
                            
In this study we analyzed sixteenth pharmaceutical compound in water samples and we get 
the following results in Table (4.1), Figure (4.1) (a.b.c.d.e.f.g.h.l) 
Table 4.1: The Occurrence of Pharmaceuticals in Al Qilt Catchment Area 
Pharmaceutical  
compound name 
Sampling station  
name 
Concentration of 
pharmaceutical compound 
  28/11/2012 15/04/2013 
Ibuprofen AWWTP inffluent 300ng/L 1000ng/L 
AWWTP effluent <BG <BG 
Mukhmas Wadi Quelle <BG <BG 
Ras Al Qilt Quelle <BG <BG 
Al Murashahat influent <BG <BG 
Al Murashahat effluent <BG <BG 
Diclofinac AWWTP inffluent 310ng/L 1450ng/L 
AWWTP effluent 50ng/L 225ng/L 
Mukhmas Wadi Quelle 100ng/L 70ng/L 
Ras Al Qilt Quelle <BG <BG 
Al Murashahat influent <BG <BG 
Al Murashahat effluent <BG <BG 
Carbamazepine AWWTP inffluent 1995ng/L 1450ng/L 
AWWTP effluent 1750ng/L 2000ng/L 
Mukhmas Wadi Quelle 1550ng/L 1995ng/L 
Ras Al Qilt Quelle 64ng/L 82ng/L 
Al Murashahat influent <BG 48ng/L 
Al Murashahat effluent <BG 44ng/L 
  
 
 
 
 
 
 
 
Figure 4.1.a: Concentration of pharmaceuticals in Al 
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Figure 4.1.c: Concentration of pharmaceuticals in Ras Al Qilt
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Figure 4.1.d: Concentration of pharmaceuticals in 
 
 
 
 
 
 
 
 
 
Figure 4.1.e: Concentration of pharmaceuticals in Al Bireh influent
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Figure 4.1.f: Concentration of pharmaceuticals in Mukhmas wadi
 
 
 
 
 
 
 
 
Figure 4.1.g: Concentration of pharmaceuticals in Ras Al Qilt
 
 
 
 
 
 
 
 
 
Figure 4.1.h: Concentration of pharmaceuticals in Aqpat Jaber
treatment in the water treatment plant
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Figure 4.1.l: Concentration of pharmaceuticals in Aqpat Jaber
treatment in the water treatment plant
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Sixteenth pharmaceutical compounds were analyzed in the water samples, namely 
Phenacetin, Indomethacin, Diclofinac, Ibuprofen, Fenoprofen, Ketoprofen, Gemfibrozil, 
Fenofibrat, Fenofibrinsaure, Bezafibrat, Clofibrinsäure, Carbamazepin, Pentoxifyllin, 
Naproxen, Diazepam, Etofibrat. In all of those, only Ibuprofen, Diclofinac and 
Carbamazepine were detected and the other are nil. The values of these compounds 
decreasing through the system (going from the first sampling station at the effluent of 
AWWTP to last sampling station in Murashahat) in decreasing the values of Ibuprofen, 
Diclofinac, Carbamazepine. This was due to the dilution process.  
Moving from AWWTP to Al Murashahat, the highest values measured pharmaceutical 
compounds were registered for AWWTP effluent. The lowest values recorded downstream 
due to the dilution process through the wadis because of the discharge that come from Ein 
Fara, Ein Jumaiz, Ein Al-Ru’yan, Ein Al Fawwar and Ein Al Qilt springs into the wadis. 
AWWTPs use activated sludge processes through which microorganisms are used for 
mineralization the pollutants into water and carbon dioxide.It is possible to remove the 
Pollutants from water by stripping into air or by sorption onto sludge that is discharged 
orderly. Some substances may be undergo photo-transformation process. Thus, the 
elimination of pharmaceutical residues in activated sludge processes includes four 
mechanisms: biotransformation, air stripping, sorption and photo-transformation (Zhang et 
al., 2008). 
There are  an absence of these compounds Phenacetin, Indomethacin, Ketoprofen, 
Gemfibrozil, Fenofibrat, Bezafibrat, Clofibrinsäure, Pentoxifyllin, Naproxen, Diazepam, 
Etofibrat in the four sampling station except  Indomethacin also detected in the AWWTP 
with low concentration 60 ng/L below background and then it was disappear and then these 
compound is eliminated due to their biodegradability in water. The results revealed that 
there are three compounds with low concentrations present in the different sampling 
station, these compound are Ibuprofen, Diclofinac, Carbamazepine. These compounds 
have a high consumption rate in Palestine. Results showed variation in these compound 
concentration  in the analyzed samples in different sample stations and it decrease with 
distance due to the dilution process to varying extent being which depend upon factors 
such as stream flow rate conditions and percentage of treated wastewater in the receiving 
water bodies. The results revealed the concentration of pharmaceutical compounds in the 
four stations. According to these results we saw that the presence of Ibuprofen only in the 
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AWWTP effluent in the first and second sampling time with a concentration of 300 ng/L 
and 1000 ng/L respectively and then disappeared in other sampling stations. Ibuprofen can 
remove in WWTPs for more than 90% (Schuman, 2008). Biotransformation is considered 
as a potential elimination pathway of ibuprofen. The metabolites of Ibuprofen can be 
removed efficiently, then it is not considered to be persistent. In the lake only the parent 
compound is determined and none of its metabolites (Buser et al. 1999).   
Diclofinac was detected in AWWTP influent in the two sampling time with a 
concentration of 310ng/L in the first sampling time and 1450ng/L in the second sampling 
time. This concentration was decreased after treatment to 50ng/L and 225ng/L 
respectively. This mechanism of treatment can not eliminate pharmaceutical compounds 
completely. For Diclofinac, the elimination activity varies so much between different STPs 
in different studies. There is no elimination of Diclofinac in three Swiss STPs. (Tauxe- 
Wuersch et al., 2005). The average of elimination of diclofenac ranging from 17% (up to 
75% (Stumpf et al., 1999; Ternes, 1998). Diclofinac is considered non-persistent  in the 
environment, and decreases quickly in rivers (Bendz et al., 2005) and lakes (Buser et al., 
1998). Diclofinac is an Acid and found in the aquatic environment as an anion, which 
interpret a high solubility and very low volatilisation. Several studies were presented  for 
monitoring the activity of elimination of pharmaceutical residues including Diclofinac and 
Carbamazepine. The results revealed that the activity of elimination of Diclofinac by 
WWTPs vary according to the study conducted by (Zhang et al., 2008). It revealed that the 
activity of elimination ranging from 0% up to 80%, but mainly in the way of 21–40% in 
wastewater treatment plants (Figure 4.1). 
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Figure 4.2: Removal efficiency distributions of Carbamazepine and Diclofenac in 
WWTPs (Zhang et al., 2008) 
 
A study was conducted by (Quintana et al., 2005) to investigate the biodegradation of 
Diclofenac by activated sludge. It shows that there are no transformation of Diclofenac 
over 28 days, neither when Diclofinac was the sole source of carbon (20 mg L−1). 
Diclofenac shows poor biodegradation  in batch elimination experiments using sludge from 
WWTPs and MBR, respectively. According to the result in Figure (4.1), the removal 
efficiency of Diclofinac could be up to 80% but for Carbamazepine was mostly below 
10%. This variation might be that Carbamazepine is not biodegraded at low concentrations 
while biodegradation of  Diclofinac may be possible under some conditions. The activity 
of elimination of these compounds is independent of the sludge retention time (SRT) 
(Clara et al. 2004; Kreuzinger et al., 2004).  
 Concentration of Diclofinac in wadi Mukhmas was increased in  the first sampling time to 
100ng/L due to mixing of not treated wastewater that come from Qalandia camp, then the 
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concentration of Diclofinac was disappeared in the last sample stations (Ras Al Qilt, Al 
Murashahat in Aqpat Jaber) which also showed that Diclofinac is not very persistent in the 
wadi Al Qilt, that it is rapidly degraded, most likely via direct photolysis when it is 
transported downstream .The main removal process of Diclofinac is Phototransformation 
(Tixier et al., 2003).  The half-life of Diclofinac exposed to sunlight was less than 1 h 
(Zhang et al., 2008). (Packer et al., 2003) proved in their study that the presence of 
isopropyl alcohol, a radical quencher in  Diclofinac is responsible for the rapid 
phototransformation of (Diclofinac in purified water, de-ionized water and Mississippi 
River water. In addition, Diclofinac having no large presence in groundwater to some 
extent due to  its low mobility (Buser et al., 1999) .  This study found a variation in the 
Diclofinac concentration in the two sampling period, the concentration of it is higher in the 
second sampling time than in the first sampling time in the AWWTP influent and effluent 
(1450 ng/L, 225 ng/L) respectively, may due to the seasonal variations in the consumption 
rate and elimination rates by humans and by WWTPs. 
Carbamazepine was detected in AWWTP influent with a concentration of 1995 ng/L in the 
first sampling time and then decreased respectively to become 1750 ng/L in AWWTP 
efluent, 1550 ng/L in wadi Mukhmas, 64 ng/L in Ras Al Quilt to reach a value lower than 
background in al Murashahat influent and effluent. As we saw that Carbamazepine 
concentrations tend to decrease with increasing distance of the catchment area (Table 4.2). 
Table 4.2: Distance between sample stations and the presence of pharmaceuticals in it.  
Station 
name 
St.1 
Al-Bireh 
WWTP 
St.2 
Mukhmas 
St.3 
Ras Al-Qilt 
St.4 
Water filtration plant 
(Al Murshahat) 
Distance 
from (Km) 
0 5.2 19.5 27.5 
Drug Ibuprofen 
Diclofinac 
Carbamazepine 
Diclofinac  
Carbamazepine 
Diclofinac  
Carbamazepine 
Carbamazepine 
 
 The measured concentration may decrease due to the dilution and flushing. The photolysis 
of Carbamazepine under sunlight irradiation occur at relatively low rate, therefore we can 
say this compound is persistent in surface waters. The measured concentration of 
Carbamazepine in the second sampling time was 1450 ng\L in AWWTP influent, 2000 
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ng/L effluent, 1995 ng/L in wadi Mukhmas, 82 ng/L in Ras Al Qilt, 48 ng/L in al 
Murashahat influent and 42ng/L in al Murashahat effluent. There are some variations in a 
concentrations between first and second sampling time. As we saw the concentration in 
AWWTP influent in the second sampling time was lower than the concentration in the first 
sampling time may be due to the decrease consumption of these pharmaceutical compound 
during this period, then the concentration of these compound increased in the AWWTP 
effluent. This increase might be because of a fast sorption of CBZ in the beginning than its 
desorption due to aging (decay, changing of structure of activated sludge enabling a better 
extraction of considered compound in the analytical method) of the activated sludge, or 
may be due to possible accumulation processes of degradates and parent compounds 
(Jimenez et al., 2011). Another interpretation is the daily concentration fluctuations during 
the sampling period (Clara et al., 2004). Or the separation of glucuronide conjugates of 
those pharmaceuticals by enzymatic processes in the treatment plant (Vieno et al., 2005). 
So it is difficult to estimate the biodegradation of pharmaceutical residues since it is 
difficult to distinguish the bio-reduction from the separation increase. 
Then, the concentration decrease in wadi Mukhmas with not significant value because of 
mixing of nontreated wastewater from Qalandia camp and Al Ram then decrease to 82ng/L 
in Ras Al Qilt and 48ng/L in JWTP influent due to the dilution and finally decrease to 
42ng/L in JWTP effluent which is not significant amount because Carbamazepin is 
typically degraded with less than 10% during the wastewater treatment process. Most 
studies confirmed this issue. Properties of Carbamazepine may be the reason for its low 
elimination activity, thes properties include; first, it is resistant to biodegradation at low 
concentrations, secondly, it is hardly attached onto sludge (Nguyen,B., 2012).  
Carbamazepine and Diclofinac, as discussed above, are examples of pharmaceutical 
compounds that have poor removal by WWTPs. These compounds have been determined 
in WWTP effluents, surface waters, groundwater and occasionally in drinking water, with 
succesive concentrations due to dilution and some removal processes as soil retention and 
phototransformation. Those compounds have been detected in WWTP effluents and in 
surface waters in some countries (Figure 4.2). There is a significant difference in the 
concentrations of these compounds among countries. This difference can be explained by 
the variation in the consumption rates of both pharmaceutical compounds in those 
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countries and due to the not enough investigations that carried out so far in the countries 
that do not have high concentration. 
 
Figure 4.3: Average detected concentrations of Carbamazepine and Diclofinac in WWTP 
effluents (a) and surface waters (b) in some countries. Source (Zhang et al., 2008) 
 
Because of the absence of functional groups that hydrolyze easily under environmental 
conditions in this compounds hydrolysis is not expected to be an important environmental 
fate process(Alshouli, 2012). It is possible for Carbamazepine to pass through an 
unsaturated underground zone and reach an aquifer. It was not degraded during its passage 
through underground/groundwater passage (Clara et al., 2004). 
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Andreozzi et al. (2003) showed in their study that presence of humic substances hindered 
phototransformation of Diclofinac and Carbamazepine while nitrate enhanced the 
phototransformation rate of these compounds. Although, of the positive effect of 
phototransformation in the environment for reducing drug levels it can lead to formation of 
transformation product which are more stable and toxic than the parent compounds, e.g. 
the carcinogenic acridine is formed during phototransformation of Carbamazepine. 
Marei and Tiehm (2007) studied the occurrence of pharmaceuticals in Palestine and in 
Jordan in certain sites and gained a results similar with the results of this study for the 
target compounds (Ibuprofen, Diclofinac and Carbamazepine) (Figures 4.3 a and b), 
 
Figure 4.4a: Pharmaceuticals in Jordan (Marei and Tiehm, 2007) 
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Figure 4.4b: Pharmaceuticals in Palestine (Marei and Tiehm, 2007) 
 
4.2 Effect and Risk of pharmaceuticals                                                           
                            
In this study we note that the target pharmaceuticals were decrease until to disappear in the 
last station except Carbamazepine that present all stations of the catchment area due to the 
previous reasons we mentioned that is first, it is resistant to biodegradation at low 
concentrations, secondly, it is hardly attached onto sludge. The Carbamazepine guidance 
value in drinking water is 40 ppb in MDH/USA. The highest concentration reported in the 
USA was 40 ng/l for meprobamate (Ferarri, 2004). The concentrations of pharmaceuticals 
in groundwater and surface water sources impacted by wastewater discharges are typically 
less than 0.1 µg/L, and concentrations in treated drinking-water are usually well below 
0.05 µg/L (WHO, 2011). The effect of pharmaceuticals and their residues in aquatic 
environment are in most cases restricted to short term acute responses such as lethality in 
algae, invertebrates and fish (Webb, 2001). The chronic effects of pharmaceutical 
compounds are scarcely tested. To carry out accurate environment risk assessment, a long 
term exposures are essential . Elevated accumulation of Diclofinac in aquatic tissues were 
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reported, despite its low lipid solubility (Oaks et al., 2004). The chronic effect of Ibuprofen 
could have interaction with estrogen homeostasis of Medaka fish (Han et al., 2005). 
Table 4.3: Effects of ibuprofen, Diclofinac and Carbamazepine on various aquatic 
organisms at low pharmaceutical concentration (ng/L - µg/L). 
Drug Effect Concentration 
Ibuprofen Significant decrease in activity of crustacean 
G. pulex 
1 and 10 ng/L 
 Toxic effects to microbial communities 10 µg/L 
 Growth inhibition of duckweed L. minor, up 
to 25% 
1,10,100 and 1000 µg/L 
Diclofinac Subtle sub cellular effects in fish 1 µg/L 
 Renal lesions and alteration of gills in fish 5 µg/L 
Carbamazepine Slightly earlier maturation and reproduction 
of Daphnia and higher production of 
offspring 
1 µg/L 
 
According to the results of this study there is no comparison in the effect of ibuprofen 
because ibuprofen was disappear in WWTP. In case of diclofinac the concentration of it is 
below the concentration in the table above then there is no risk. In case of carbamazepine 
the concentration of it in this study was 1550ng\L and 1995ng\L in Mukhmas bridge in 
first and second sampling time and this concentration is higher than the concentration in 
the table above(1 microgram) and may cause a risk on small animals such as daphnia.In the 
Ras al Qilt and Al Murashat the concentration is below 1microgram then there is no risk. 
Ferrari et al. (2003) studied the toxic effects of Diclofinac and Carbamazepine on algae, 
bacteria, fish and microcrustaceans. They reported that both Carbamazepine and Diclofinac 
had a relatively limited acute eco-toxicity on the tested organisms and chronic tests 
displayed higher toxicity than acute tests (see Table 4.4). 
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Table 4.4: Effects of ibuprofen, Diclofinac and Carbamazepine on various aquatic 
organisms at low pharmaceutical concentration. (Zhang et al., 2008) 
 Acute toxicity EC50 Chronic toxicity 
NOEC 
PNEC 
Carbamazepine >13.8–81 mg L−1 25–100 mg L−1 0.42 µg L−1 
 
1–10 mg L−1  6.359 µg L−1 
 
4.5–383.5 mg L−1   
 
75.1–502.6 mg L−1   
Diclofinac 11.5– 22.7 mg L−1 1–10 mg L−1 116 µg L−1 
 
1–10 mg L−1  138.74 µg L−1 
 
3.3–142.2 mg L−1   
 
90 ± 20 µg L−1 on zebra fish 
embryos. 
  
 
68 mg L−1 45 mg L−1  
 
 1 mg L−1 on Daphnia 
magna and 1 µg L−1 
on histopathological 
lesions 
 
EC50: concentrations that cause 50% of effect. 
NOEC: no observed effect concentration. 
PNEC: predicted no-effect concentrations. 
Pharmaceuticals in the environment have an effect on animal like birds such as vultures, 
raptors, cranes and owel. A study by Oaks et al. (2004) showed that the death of between 
34 and 95% of the population of oriental white-backed vultures, was linked to the 
consumption of water contaminated with Diclofinac, a painkiller widely used by the 
human population that cause kidney failure and visceral gout in birds. In addition, it has 
also been found that detrimental effects may happen by the transfer of compounds within 
the food web. 
Diclofinac is reported to negatively affect vulture populations in Southeast Asia (Pakistan, 
India, Bangladesh and Nepal), as it caused a severe Decline of vultures, after feeding 
themselves with domestic livestock and cattle, which were given Diclofinac (Oaks, 2004). 
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Old world vultures consume dead livestock that eat the carcass which having diclofinac in 
their body, as Diclofinac is used for treatment sick livestock in Asia. Dose of only 1 mg of 
these drug  causes acute kidney failure and death within a few days. Many studies 
confirmed that ingestion of residues of the Diclofinac causes high mortality rate.  
The impact of Diclofinac on the mortality, growth, and development of fish was studied by 
Svobodova et al. (2013). They reported that the exposure to Diclofinac at 3mg/L was 
associated with increased mortality, increased activity of glutathione S-transferase, and 
decreased activity of glutathione reductase. 
4.3 Effect of target pharmaceuticals on groundwater                                    
                            
NSAIDs reach groundwater when municipal wastewater or biosolids are applied in soils 
then it may migrate through soils or be transformed in it ending into groundwater. CBZ has 
poor sorption and relative persistence which suggest that it may pose a high leakage risk 
for groundwater contamination when recycled for irrigation . Carbamazepine had the 
lowest concentration at the top soil layers which have the highest organic carbon content, 
which means that there is potential degradation of Carbamazepine in surface 
soils. Carbamazepine also showed significant accumulation from year to year (McLain and 
Williams, 2012). Soils may adsorb CBZ and making it to move slowly into groundwater 
(Williams et al., 2012). Carbamazepine and Diclofinac are classified as slow-mobile 
compounds in SOM-rich soil layers. They showed high mobility when introduced into 
SOM-poor soils, and their mobility increases significantly . Chemicals' characteristics 
(such as pK(a) values) and soil properties influence the mobility of NSAIDs in 
soil.According to the results of this study the concentration of Target compounds was 
below background and disappear in Ras Al Qilt and in Al Murashahat except 
carbamazepine which was near the background so it has no risk on it. 
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4.4 Conclusions 
*  Findings of this study show the following: 
*  Ibuprofen is detected only in the AWWTP effluent in the first and second sampling time 
with a concentration of 300 ng/L and 1000 ng/L respectively, and then disappeared in 
other sampling stations because it was efficiently removed in AWWTP.  
*  Diclofinac was detected in AWWTP influent in the two sampling time with a 
concentration of 310ng/L in the first sampling time and 1450ng/L in the second sampling 
time. This concentration was decreased after treatment to 50ng/L and 225ng/L 
respectively. Then it was disappeared in Ras Al Qilt and in Al Murashahat due to the 
photodegradation process.  
*  Carbamazepine was detected in AWWTP inffluent with a concentration of 1995 ng/L in 
the first sampling time and then decreased respectively to become 1750 ng/L in AWWTP 
effluent, 1550 ng/L in wadi mukhmas, 64 ng/L in ras al quilt  to reach a value lower than 
background in al murashahat influent and effluent. 
*  Only Carbamazepine were detected in the Ras Al Qilt in the first and second sampling 
time and in Al Murashahat influent and effluent in the second sampling time, where the 
highest values were recorded for AWWTP effluent.   
    * The concentration of pharmaceutical compounds(Ibuprofen, Diclofinac, 
Carbamazepine) on Al Qilt catchment area are below background or near it, then they 
have no risk on groundwater and public health. According to the literature review it may 
have a risk on small animals as inertebrates and fish when it found in a concentration 
higher than the concentration that detected in this study with significant value and do not 
have a risk on human. 
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4.5 Recommendations`                                                                                      
                            
To reduce the pharmaceutical environmental pollution, it is recommended to: 
1. Back to alternative medicine and using herbs to reduce the pharmaceutical pollution, 
which they finished in the water. 
2. Emphasis monitoring on pharmacies and inhibitthem from selling medicines randomly 
and without medical prescription. 
3. Studies should be conducted for other chemical pollutants such as endocrine disruptor 
chemicals (EDC), hormone imposters, sex hormone pollution which distort the 
reproductive organs of animal life. 
4. Interested ministries must be determine the responsibilities towards pharmaceuticals 
waste management in Palestine. 
5. It must be apply more laws and regulations linked to pharmaceuticals waste 
management outside health care centers. 
6. More researches in this regard should be carried out, further investigation into the fate of 
Ibuprofen, Diclofinac, Carbamazepinee in the environment which include:Degradation 
rates, local and global distribution, toxicity of it to understand their risk on water bodies 
and drinking water.  
7. Further improvement and validation of the employed methods for the analysis of these 
pharmaceuticals in water. 
8. Studying the effect of these pharmaceuticals on public health and environment in other 
places in Palestine. . 
9. Disposal of expired pharmaceuticals by healthy way, and improve the methods of 
pharmaceutical removal in wastewater treatment plants.  
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